日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/04/13 | 8,730 | 9,050 | 8,720 | 9,010 | +160 | +1.8% | 260,800 |
| 2022/04/12 | 8,860 | 8,990 | 8,790 | 8,850 | -120 | -1.3% | 231,600 |
| 2022/04/11 | 8,730 | 8,990 | 8,710 | 8,970 | +230 | +2.6% | 286,800 |
| 2022/04/08 | 8,550 | 8,760 | 8,480 | 8,740 | +340 | +4% | 456,400 |
| 2022/04/07 | 8,050 | 8,400 | 8,050 | 8,400 | +340 | +4.2% | 220,900 |
| 2022/04/06 | 8,090 | 8,170 | 8,010 | 8,060 | -150 | -1.8% | 205,800 |
| 2022/04/05 | 8,300 | 8,330 | 8,170 | 8,210 | -110 | -1.3% | 172,800 |
| 2022/04/04 | 8,280 | 8,350 | 8,180 | 8,320 | +80 | +1% | 154,400 |
| 2022/04/01 | 8,320 | 8,390 | 8,220 | 8,240 | -90 | -1.1% | 156,800 |
| 2022/03/31 | 8,540 | 8,620 | 8,330 | 8,330 | -220 | -2.6% | 166,000 |
| 2022/03/30 | 8,740 | 8,770 | 8,430 | 8,550 | -140 | -1.6% | 147,300 |
| 2022/03/29 | 8,690 | 8,750 | 8,580 | 8,690 | +120 | +1.4% | 156,000 |
| 2022/03/28 | 8,740 | 8,740 | 8,540 | 8,570 | -130 | -1.5% | 101,500 |
| 2022/03/25 | 8,620 | 8,710 | 8,560 | 8,700 | +60 | +0.7% | 104,700 |
| 2022/03/24 | 8,710 | 8,740 | 8,560 | 8,640 | -20 | -0.2% | 150,200 |
| 2022/03/23 | 8,610 | 8,680 | 8,500 | 8,660 | +310 | +3.7% | 196,300 |
| 2022/03/22 | 8,530 | 8,610 | 8,290 | 8,350 | -50 | -0.6% | 245,700 |
| 2022/03/18 | 8,300 | 8,490 | 8,280 | 8,400 | +160 | +1.9% | 229,700 |
| 2022/03/17 | 8,470 | 8,470 | 8,230 | 8,240 | -80 | -1% | 223,900 |
| 2022/03/16 | 8,200 | 8,410 | 8,180 | 8,320 | +230 | +2.8% | 304,400 |
| 2022/03/15 | 7,810 | 8,160 | 7,780 | 8,090 | +240 | +3.1% | 190,000 |
| 2022/03/14 | 7,770 | 7,910 | 7,760 | 7,850 | +130 | +1.7% | 175,200 |
| 2022/03/11 | 7,860 | 7,950 | 7,690 | 7,720 | -210 | -2.6% | 169,500 |
| 2022/03/10 | 7,900 | 7,960 | 7,790 | 7,930 | +270 | +3.5% | 254,200 |
| 2022/03/09 | 7,780 | 7,890 | 7,640 | 7,660 | -40 | -0.5% | 198,700 |
| 2022/03/08 | 7,660 | 7,820 | 7,660 | 7,700 | +140 | +1.9% | 287,400 |
| 2022/03/07 | 7,430 | 7,630 | 7,430 | 7,560 | -80 | -1% | 183,000 |
| 2022/03/04 | 7,640 | 7,740 | 7,540 | 7,640 | +30 | +0.4% | 217,000 |
| 2022/03/03 | 7,460 | 7,650 | 7,400 | 7,610 | +230 | +3.1% | 166,100 |
| 2022/03/02 | 7,360 | 7,450 | 7,350 | 7,380 | +40 | +0.5% | 210,100 |
| 2022/03/01 | 7,420 | 7,510 | 7,310 | 7,340 | -110 | -1.5% | 166,400 |
| 2022/02/28 | 7,320 | 7,470 | 7,300 | 7,450 | +90 | +1.2% | 160,600 |
| 2022/02/25 | 7,400 | 7,430 | 7,250 | 7,360 | ±0 | ±0% | 192,400 |
| 2022/02/24 | 7,380 | 7,430 | 7,280 | 7,360 | -100 | -1.3% | 152,300 |
| 2022/02/22 | 7,510 | 7,510 | 7,360 | 7,460 | -110 | -1.5% | 137,000 |
| 2022/02/21 | 7,560 | 7,630 | 7,510 | 7,570 | -140 | -1.8% | 107,500 |
| 2022/02/18 | 7,550 | 7,740 | 7,550 | 7,710 | +40 | +0.5% | 141,300 |
| 2022/02/17 | 7,770 | 7,790 | 7,630 | 7,670 | -150 | -1.9% | 162,400 |
| 2022/02/16 | 7,800 | 7,860 | 7,700 | 7,820 | +50 | +0.6% | 186,600 |
| 2022/02/15 | 7,740 | 7,820 | 7,680 | 7,770 | +20 | +0.3% | 201,100 |
| 2022/02/14 | 7,540 | 7,780 | 7,500 | 7,750 | -20 | -0.3% | 198,000 |
| 2022/02/10 | 7,710 | 7,840 | 7,680 | 7,770 | +70 | +0.9% | 200,500 |
| 2022/02/09 | 7,680 | 7,760 | 7,630 | 7,700 | +40 | +0.5% | 152,900 |
| 2022/02/08 | 7,630 | 7,700 | 7,560 | 7,660 | +20 | +0.3% | 154,700 |
| 2022/02/07 | 7,650 | 7,690 | 7,610 | 7,640 | -10 | -0.1% | 130,500 |
| 2022/02/04 | 7,520 | 7,680 | 7,520 | 7,650 | +70 | +0.9% | 123,700 |
| 2022/02/03 | 7,530 | 7,610 | 7,490 | 7,580 | -30 | -0.4% | 111,200 |
| 2022/02/02 | 7,470 | 7,640 | 7,470 | 7,610 | +120 | +1.6% | 118,600 |
| 2022/02/01 | 7,550 | 7,660 | 7,470 | 7,490 | +20 | +0.3% | 106,500 |
| 2022/01/31 | 7,470 | 7,520 | 7,390 | 7,470 | ±0 | ±0% | 189,000 |
751～
800
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 336,300円 | +8.0% | -15.3% | 3.69% | 9.44倍 | 0.92倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 434,700円 | +20.9% | +87.3% | 3.13% | 9.71倍 | 1.12倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 191,600円 | +5.0% | +1.5% | 0.00% | 16.45倍 | 4.38倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 199,000円 | +4.0% | +25.4% | 2.66% | 8.70倍 | 1.14倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 415,500円 | +3.6% | +6.1% | 2.89% | 14.46倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
